McCarthy Danielle M, Cameron Kenzie A, Courtney D Mark, Adams James G, Engel Kirsten G
Professor and Chair, Department of Emergency Medicine, Northwestern University, Chicago, Illinois.
Assistant Professor, Department of Emergency Medicine, Northwestern University, Chicago, Illinois.
J Opioid Manag. 2015 May-Jun;11(3):229-36. doi: 10.5055/jom.2015.0271.
The Medication Communication Index (MCI) was used to compare counseling about opioids to nonopioid analgesics in the Emergency Department (ED) setting.
Secondary analysis of prospectively collected audio recordings of ED patient visits.
Urban, academic medical center (>85,000 annual patient visits).
Patient participants aged >18 years with one of four low acuity diagnoses: ankle sprain, back pain, head injury, and laceration. ED clinician participants included resident and attending physicians, nursing staff, and ED technicians.
The MCI is a five-point index that assigns points for communicating the following: medication name (1), purpose (1), duration (1), adverse effects (1), number of tablets (0.5), and frequency of use (0.5). Recording transcripts were scored with the MCI, and total scores were compared between drug classes.
The 41 patients received 56 prescriptions (27 nonopioids, 29 opioids). Nonopioid median MCI score was 3 and opioid score was 4.5 (p=0.0008). Patients were counseled equally about name (nonopioid 100 percent, opioid 96.6 percent, p=0.34) and purpose (88.9 percent, 89.7 percent, p=0.93). However, patients receiving opioids were counseled more frequently about duration of use (nonopioid 40.7 percent, opioid 69.0 percent, p=0.03) and adverse effects (18.5 percent, 93.1 percent, p<0.001). In multivariable analysis, opioids (β=0.54, p=0.04), number of medications prescribed (β=-0.49, p=0.05), and time spent in the ED (β=0.007, p=0.006) were all predictors of total MCI score.
The extent of counseling about analgesic medications in the ED differs by drug class. When counseling patients about all analgesic medications, providers should address not only medication name and purpose but also the less frequently covered topics of medication dosing, timing, and adverse effects.
使用药物沟通指数(MCI)比较急诊科(ED)环境中关于阿片类药物与非阿片类镇痛药的用药指导情况。
对前瞻性收集的急诊科患者就诊音频记录进行二次分析。
城市学术医疗中心(每年患者就诊量>85000人次)。
年龄>18岁、患有以下四种低 acuity 诊断之一的患者:脚踝扭伤、背痛、头部受伤和撕裂伤。急诊科临床医生参与者包括住院医师和主治医师、护理人员以及急诊科技术人员。
MCI 是一个五分制指数,为以下沟通内容赋值:药物名称(1 分)、用途(1 分)、疗程(1 分)、不良反应(1 分)、药片数量(0.5 分)和使用频率(0.5 分)。对录音文字记录进行 MCI 评分,并比较不同药物类别之间的总分。
41 名患者共收到 56 张处方(27 张非阿片类药物处方,29 张阿片类药物处方)。非阿片类药物的 MCI 中位数为 3 分,阿片类药物为 4.5 分(p = 0.0008)。患者在药物名称(非阿片类药物 100%,阿片类药物 96.6%,p = 0.34)和用途(88.9%,89.7%,p = 0.93)方面得到的指导相同。然而,接受阿片类药物治疗的患者在使用疗程(非阿片类药物 40.7%,阿片类药物 69.0%,p = 0.03)和不良反应(18.5%,93.1%,p<0.001)方面得到的指导更为频繁。在多变量分析中,阿片类药物(β = 0.54,p = 0.04)、开具的药物数量(β = -0.49,p = 0.05)和在急诊科的停留时间(β = 0.007,p = 0.006)均为 MCI 总分的预测因素。
急诊科中关于镇痛药的用药指导程度因药物类别而异。在为患者提供所有镇痛药的用药指导时,医护人员不仅应提及药物名称和用途,还应涉及用药剂量、用药时间和不良反应等较少提及的话题。